ESR Life, Events, Publications and Outreach , , , by

European Researcher’s Night 2018 – Who is Who

META-CAN has participated in this European event with the activity entitled: WHO is WHO in European Science? / QUI és QUI en la Recerca a Europa? Developed in the ImaginCafè (Barcelona) on Friday 28th of September 2018 (20 - 22:00h).
Read more
ESR Life, Events , , by

Scientific Traning @EMBO Workshop

META-CAN collaborated in this year’s EMBO Cancer Signaling and Cancer Therapy workshop as part of our ESRs’ scientific training. This …
Read more
Blog, Events, News , , by

EMBO Workshop – Cellular Signalling and Cancer Therapy

This workshop is the third in a series of EMBO meetings and represents the continuation of the signal transduction Dubrovnik …
Read more
Blog, Events, News by

1st META-CAN Workshop

The first META-CAN workshop took place in Nice, France, from the 16th– 20th of April. This was the very first …
Read more
Events, News by

Kick-off meeting

The MSCA-ITN META-CAN celebrated its Kick-off Meeting, the 20 th of October, in Barcelona. The objective of this meeting was …
Read more
Recent Posts
Archives
Upcoming Events

  1. 2nd Metabolism in Health and Disease Conference

    10 May, 2021 - 13 May, 2021

View All Events

LATEST PUBLICATIONS

META-CANFollow

META-CAN
Retweet on TwitterMETA-CAN Retweeted
Aromics Biotech@aromicsbiotech·
9 Dec

📌@aromicsbiotech, among the 175+ European companies that will present its advances in the 3th edition of @TechTourHQ Contest Final to an international audience of 350+investors, key corporates &innovation experts ▶️https://t.co/hy204evuZG

#TTFinal19 #BermesProject

3
Reply on TwitterRetweet on Twitter2Like on Twitter7Twitter
Retweet on TwitterMETA-CAN Retweeted
Powell Lab@J_Powell_Lab·
27 Nov

fantastic work in @sciencemagazine from our own @bobdleone about glutamine antagonism in cancer. double-edged sword that suppresses tumor metabolism and increases functionality of the TIL. #immunotherapy #immunometabolism

Reply on TwitterRetweet on Twitter13Like on Twitter27Twitter
Load More...